Stringent Datalytics - Healthcare’s Post

🌟 𝐀𝐧𝐚𝐬𝐭𝐨𝐦𝐨𝐬𝐢𝐬 𝐀𝐬𝐬𝐢𝐬𝐭 𝐃𝐞𝐯𝐢𝐜𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐚𝐧𝐝 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐎𝐮𝐭𝐜𝐨𝐦𝐞𝐬 🏥🔬📈 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/g9XXk2tZ 📊 Market Overview: The Anastomosis Assist Device Market is expanding rapidly, driven by the rising number of surgical procedures, particularly cardiovascular and gastrointestinal surgeries. These devices include various types of staplers, suturing devices, and robotic systems designed to enhance the accuracy and efficiency of anastomosis procedures. 🌟 Key Trends and Insights: Technological Advancements: Innovations in surgical technology, such as robotic-assisted devices and automated suturing systems, are enhancing the precision and safety of anastomosis procedures. Growth in Minimally Invasive Surgeries: The increasing preference for minimally invasive surgeries, which offer faster recovery times and reduced post-operative complications, is driving the demand for advanced anastomosis assist devices. Rising Prevalence of Cardiovascular Diseases: The global rise in cardiovascular diseases, necessitating coronary artery bypass graft (CABG) surgeries, is significantly boosting the market for anastomosis assist devices. Focus on Patient Outcomes: There is a growing emphasis on improving patient outcomes by reducing the risk of leaks, infections, and other complications associated with traditional anastomosis techniques. Integration of AI and Machine Learning: The integration of artificial intelligence (AI) and machine learning in surgical devices is aiding in the development of more precise and efficient anastomosis assist devices. #Company Medtronic Maquet Guidant Terumo Europe #Type Reusable Disposable #Application Cardiovascular Surgeries General Surgeries Gynecological Surgeries Orthopedic Surgeries Ophthalmic Surgeries Others #AnastomosisAssistDevices #SurgicalTechnology #HealthcareInnovation #MinimallyInvasiveSurgery #CardiovascularHealth #RoboticSurgery #PatientOutcomes

Minimally Invasive Surgery Market Set to Soar: $173.9 Billion by 2029! 💉🔍 Download PDF Brochure: https://lnkd.in/d5Ms4vx5 The global Minimally Invasive Surgery (MIS) market is projected to reach a whopping USD 173.9 billion by 2029, up from USD 79.3 billion in 2024, with a CAGR of 17.0% over the forecast period. 🌐📈 So, what's driving this robust growth? 🤔 1️⃣ Increasing demand for MIS procedures due to their precision, reduced pain, and quicker recovery times. 2️⃣ Rising prevalence of chronic diseases and an aging global population requiring surgical interventions. 3️⃣ Surge in public-private investments supporting clinical research and technological advancements. 4️⃣ Presence of key market players in emerging economies, fostering innovation and accessibility. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Medtronic (Ireland), Johnson & Johnson (US), NuVasive (US), Becton, Dickinson & Co. (US), Stryker Corporation (US), Zimmer Biomet Holdings (US), Abbott Laboratories (US) and Boston Scientific Corporation (US), GE healthcare (US) Other Companies that are Operating in this Market Globally: Jesús Usón Minimally Invasive Surgery Center - JUMISC  Novanta Inc. Vicarious Surgical Inc. Orchid Orthopedic Solutions DCH Health System EndoQuest Robotics™ Northwest Medical Center UFP Technologies Boehringer Laboratories, LLC Nobilis Health Corp. MidState Medical Center Lilavati Hospital & Research Centre (Official)    LivsMed ACMI NDS Surgical Imaging HCA Florida Fawcett Hospital IRCAD SEHA Corniche Hospital Spineart Distalmotion eCential Robotics SOFMEDICA Life-saving Innovation Cardinal Santos Medical Center - Colinas Verdes Hospital Managers Inc.      Euroclinic Group Newton Medical Center Del Sol Medical Center PAJUNK® The Woman's Hospital of Texas Kelina Hospital Sunrise Hospital, Cochin Schivo Intuitive Fosun Daya General Hospital Ltd. Fortis Escorts Okhla Sharon Regional Medical Center Medpark International Hospital Women's Health Texas   OrthoGeorgia The Medical City Clark Urology Associates, P.C. #HealthcareInnovation #Surgery #MinimallyInvasive #MarketTrends #MedicalDevices #Robotics #HealthcareTech

Only put off until tomorrow what you are willing to die having left undone. **Globus Medical Launches ExcelsiusHub™ Navigation System, Revolutionizing Spinal Surgery** **Quiver AI Summary** Globus Medical, Inc. has made an exciting announcement regarding the commercial launch of its groundbreaking ExcelsiusHub™ navigation system. This cutting-edge technology is set to enhance the existing Excelsius™ ecosystem for spinal surgery by significantly improving freehand navigation through real-time visualization. By enhancing accuracy and reducing radiation exposure, this innovation aims to revolutionize spinal surgery and provide better outcomes for patients. **Empowering You to Invest in Your Health** Investing in healthcare has never been more important, and with the launch of Globus Medical's ExcelsiusHub™ navigation system, you have an extraordinary opportunity to align your investments with advancements in medical technology. By staying ahead of the curve and investing in companies that are transforming the healthcare industry, you not only have the potential to grow your Health Savings Account (HSA), but also contribute to the well-being of countless individuals and families. **Take Action Today to Prevent FOMO** Don't miss out on the potential gains and impact of investing in healthcare. Act now to ensure you are part of this transformative journey. Make the most of your HSA by investing in companies like Globus Medical, Inc., which are dedicated to advancing healthcare technology and improving patient outcomes. Together, we can create a healthier future for all. #hsa #investing #healthcare #health #family #wellness 💰💪🏥🌍

Vascular Surgery with Siemens Healthineers Cios Alpha At the cutting edge of endovascular therapy, Siemens Healthineers Cios Alpha is redefining intraoperative imaging with unparalleled precision and flexibility. As healthcare professionals, our primary aim is to provide the best care for your patients, and Cios Alpha is instrumental in achieving this goal. 🎯 Precision and Control in the OR: The Cios Alpha, equipped with a flat detector (FD), offers a 30x30 cm field of view, ensuring distortion-free images crucial for complex vascular surgeries. Its innovative design, with a spatial resolution of 1,500 x 1,500 pixels, enables surgeons to perform with confidence from head to foot, across a variety of procedures. 🎯 Advanced Technology for Better Outcomes: The device’s patented active cooling system allows for prolonged use without compromising image quality, making it ideal for extended surgical sessions. The direct controllability and motorized adjustments empower surgeons with immediate and precise image acquisition, reducing operative times and enhancing patient safety. 🎯 Tailored for Modern Vascular Therapy: From the pelvis to the peripheries, Cios Alpha supports a range of endovascular interventions, including the deployment of specialized stents and treatment of lower-leg arteries. Its high-resolution imaging is critical for accurately placing stents and detecting complications, like type 1 endoleaks, allowing for immediate corrective actions. After extensive testing, healthcare experts acknowledge Cios Alpha's significant contribution to vascular surgery, praising its image quality, especially in challenging scenarios involving obese patients or detailed vascular work. Schedule your demo today and see how Cios Alpha can transform patient care in your practice. #cardiovascular #vascular #radiology #surgery #kentucky #imaging #hospitals #healthcare #endovascular #mobile #medicaldevice

Aortic Aneurysm with Stent-Graft 🩺💡 👉 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 :  https://lnkd.in/gWtbQhKC The global market for aortic aneurysm treatment and management has been witnessing significant advancements in recent years, offering a promising outlook for patients and healthcare providers alike. Aortic aneurysm, characterized by a weakening or bulging in the wall of the aorta, the body's main artery, poses a serious health risk if left untreated. However, with evolving technologies and innovative treatment approaches, the landscape of aortic aneurysm management is undergoing a transformation. Innovative Treatment Modalities: Recent years have seen the emergence of minimally invasive techniques for treating aortic aneurysms, offering patients less invasive alternatives to traditional open surgery. Endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) have gained popularity due to their reduced risk, shorter recovery times, and improved patient outcomes compared to conventional surgical procedures. These approaches involve the placement of stent grafts via small incisions, thereby avoiding the need for large surgical openings. Technological Advancements: Advancements in imaging modalities, such as computed tomography angiography (CTA) and magnetic resonance angiography (MRA), have enhanced the preoperative planning process and improved the accuracy of aortic aneurysm diagnosis. High-resolution imaging enables clinicians to precisely visualize the size, shape, and location of aneurysms, facilitating optimal treatment selection and procedural guidance. Biomedical Engineering Breakthroughs: The field of biomedical engineering has contributed significantly to the development of novel materials and devices for aortic aneurysm repair. Innovations in stent graft design, including custom-made and fenestrated/branched devices, have expanded treatment options for complex aneurysms involving the aortic arch or visceral arteries. These advancements have enabled clinicians to tailor interventions to individual patient anatomy, enhancing treatment efficacy and long-term durability. 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Medtronic Endologix LLC Gore Medical Centre MicroPort Cook Medical Terumo Medical Corporation Maquet Holding GmbH & Co KG Lombard Medical Limited jotec Cardinal Health #aorticaneurysm

Vascular Surgery with Siemens Healthineers Cios Alpha At the cutting edge of endovascular therapy, Siemens Healthineers Cios Alpha is redefining intraoperative imaging with unparalleled precision and flexibility. As healthcare professionals, our primary aim is to provide the best care for your patients, and Cios Alpha is instrumental in achieving this goal. 🎯 Precision and Control in the OR: The Cios Alpha, equipped with a flat detector (FD), offers a 30x30 cm field of view, ensuring distortion-free images crucial for complex vascular surgeries. Its innovative design, with a spatial resolution of 1,500 x 1,500 pixels, enables surgeons to perform with confidence from head to foot, across a variety of procedures. 🎯 Advanced Technology for Better Outcomes: The device’s patented active cooling system allows for prolonged use without compromising image quality, making it ideal for extended surgical sessions. The direct controllability and motorized adjustments empower surgeons with immediate and precise image acquisition, reducing operative times and enhancing patient safety. 🎯 Tailored for Modern Vascular Therapy: From the pelvis to the peripheries, Cios Alpha supports a range of endovascular interventions, including the deployment of specialized stents and treatment of lower-leg arteries. Its high-resolution imaging is critical for accurately placing stents and detecting complications, like type 1 endoleaks, allowing for immediate corrective actions. After extensive testing, healthcare experts acknowledge Cios Alpha's significant contribution to vascular surgery, praising its image quality, especially in challenging scenarios involving obese patients or detailed vascular work. Schedule your demo today and see how Cios Alpha can transform patient care in your practice. #cardiovascular #vascular #radiology #surgery #kentucky #imaging #hospitals #healthcare #endovascular #mobile #medicaldevice #interventionalradiology #wellness #bostonscientific

🔍 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐧𝐠 𝐒𝐩𝐢𝐧𝐞 𝐒𝐮𝐫𝐠𝐞𝐫𝐲: 𝐓𝐡𝐞 𝐔𝐧𝐢𝐥𝐚𝐭𝐞𝐫𝐚𝐥 𝐁𝐢𝐩𝐨𝐫𝐭𝐚𝐥 𝐄𝐧𝐝𝐨𝐬𝐜𝐨𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 🔍 Unilateral Biportal Endoscopy Market size was $295.31 Million in 2021, and is projected to reach $548.43 Million by 2031, growing at a CAGR of 6.4% from 2022 to 2031. 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gArNjGux The Unilateral Biportal Endoscopy Market is revolutionizing the field of spinal surgery by offering minimally invasive solutions that enhance surgical precision and patient outcomes. This advanced technique is transforming how spinal conditions are diagnosed and treated, providing numerous benefits over traditional methods. 🌟 Key Highlights: Minimally Invasive Approach: Unilateral biportal endoscopy allows for smaller incisions, reducing tissue damage and promoting faster recovery times compared to conventional open surgeries. Enhanced Visualization: The use of dual portals provides surgeons with better visualization and access to the surgical site, improving accuracy and outcomes. Patient Benefits: Patients experience less postoperative pain, shorter hospital stays, and quicker return to normal activities, making this approach highly favorable. 📈 Market Dynamics: Rising Prevalence of Spinal Disorders: The increasing incidence of spinal disorders, such as herniated discs and spinal stenosis, drives the demand for advanced surgical techniques like unilateral biportal endoscopy. Technological Advancements: Continuous innovations in endoscopic equipment and techniques are enhancing the effectiveness and adoption of unilateral biportal endoscopy in spine surgery. #Company ENDOVISION KARL STORZ Smith+Nephew Stryker CONMED Corporation Maxer Endoscopy GmbH joimax Jiangsu Bonss Medical Technology Co. Ltd. Kinetix Lifesciences #Type • Reusable • Single use #Application • Hospitals • Ambulatory Surgery Centers/Clinics • Other end-users #BiportalEndoscopy #SpineSurgery #MedicalInnovation #MinimallyInvasiveSurgery #PatientCare #HealthcareTechnology #SurgicalAdvancements #GlobalHealth #Orthopedics #LinkedInPost

𝐔𝐧𝐯𝐞𝐢𝐥𝐢𝐧𝐠 𝐭𝐡𝐞 𝐒𝐮𝐫𝐠𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐈𝐦𝐚𝐠𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐭𝐨𝐰𝐚𝐫𝐝𝐬 𝐔𝐒𝐃 𝟏.𝟕𝟏 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟎 𝐆𝐞𝐭 𝐚 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞: https://lnkd.in/gPiVQFap According to the latest market analysis by Next Move Strategy Consulting, the worldwide 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐈𝐦𝐚𝐠𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 size is predicted to reach 𝐔𝐒𝐃 𝟏.𝟕𝟏 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, with a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟑.𝟗% till 2030. Minimally invasive surgical techniques, such as laparoscopy, endoscopy, and robotic-assisted surgery, have become increasingly prevalent due to their benefits of reduced trauma, faster recovery times, and improved patient outcomes. Surgical imaging systems, including fluoroscopy, C-arms, and intraoperative MRI/CT, enable surgeons to visualize internal structures and navigate complex procedures with precision, driving demand for advanced imaging technologies. Manufacturers are focused on developing surgical imaging systems with optimized imaging protocols and dose reduction techniques to minimize patient exposure to ionizing radiation during procedures. Advancements in dose monitoring, image enhancement algorithms, and radiation shielding technologies contribute to enhanced patient safety and comfort while maintaining image quality and diagnostic accuracy. 𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Canon Medical Systems Corporation GE HealthCare Genoray CO., Ltd. Hologic, Inc. Koninklijke Kentalis In conclusion, the global surgical imaging market is poised for significant growth, driven by technological advancements, increasing demand for minimally invasive surgeries, and expanding applications in interventional procedures across various medical specialties. #surgicalimaging #medicalinnovations #healthcare #technology #markettrends #industrynews

𝐈𝐦𝐚𝐠𝐞 𝐆𝐮𝐢𝐝𝐞𝐝 𝐒𝐮𝐫𝐠𝐞𝐫𝐲 𝐈𝐧𝐬𝐭𝐫𝐮𝐦𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭: 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐓𝐨𝐨𝐥𝐬 𝐒𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐒𝐮𝐫𝐠𝐞𝐫𝐲 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/dSWyYH6q The image guided surgery (IGS) instruments market is witnessing rapid growth due to advancements in imaging technologies and the increasing demand for minimally invasive surgical procedures. Image-guided surgery relies on advanced imaging techniques, such as computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and fluoroscopy, to provide real-time visualization during surgical interventions. This allows surgeons to navigate more precisely within the body, enhancing accuracy, reducing the risk of complications, and improving patient outcomes. As the adoption of image-guided procedures increases across various medical specialties, including neurosurgery, orthopedics, ENT, and oncology, the demand for specialized instruments and devices that complement these procedures is expanding. One of the key drivers of the image guided surgery instruments market is the growing preference for minimally invasive surgeries, which offer numerous benefits such as shorter recovery times, reduced scarring, and lower risk of infection. Surgeons are increasingly utilizing image-guided systems to perform complex surgeries with smaller incisions, improving surgical precision and patient safety. The rise in chronic diseases like cancer, cardiovascular diseases, and neurological disorders has also spurred the need for more accurate and effective surgical interventions, further driving the demand for image-guided surgery tools and technologies. As patient awareness about the advantages of minimally invasive procedures grows, the market for image-guided surgery instruments is set to expand. #Company Medtronic Siemens Healthcare Pvt. Ltd. GE HealthCare Philips Zimmer Biomet Analogic Integra LifeSciences #Type Computed Tomography (CT) Magnetic Resonance Imaging (MRI) X-Ray Fluoroscopy Endoscopes Position Emission Tomography (PET) Single Photon Emission Computed Tomography (SPECT) #Applications Hospitals Ambulatory Surgery Centers Others #ImageGuidedSurgery #SurgicalPrecision #MinimallyInvasiveSurgery #RoboticSurgery #SurgicalNavigation #HealthcareInnovation #MedicalDevices #AdvancedSurgery #AIinSurgery #HealthcareTech #SurgicalTools #PatientOutcomes #Neurosurgery #OrthopedicSurgery #4DImaging #SurgicalNavigationSystems #Ophthalmology #SurgicalRobotics #MedicalInnovation #SurgeonTools